Global HIV Vaccine Enterprise
Geneva, Geneva, Switzerland
Established in 2003, the Global HIV Vaccine Enterprise (the Enterprise) became a programme of IAS – the International AIDS Society – in 2018. The Enterprise unites stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of – and future access to – an HIV vaccine.
Vision:
A safe and effective vaccine available to the world.
Vision:
A safe and effective vaccine available to the world.
CONFERENCES AND COURSES
HIV Research for Prevention (HIVR4P) 2018
In-Person Event
Infectious Disease
Oct 21 - 25, 2018
Madrid, Madrid, ES
Harnessing Novel Imaging Approaches to Guide HIV Prevention and Cure Discoveries
- In-Person Event
- Infectious Disease
- May 08 - 09, 2017
- Rockville, Maryland, USA
HIV Research for Prevention 2016 : AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P)
- In-Person Event
- Infectious Disease
- Oct 17 - 21, 2016
- Chicago, Illinois, USA
HIV R4P Conference
- In-Person Event
- Infectious Disease
- Oct 28 - 31, 2014
- Cape Town, Western Cape, ZA
HIV Research for Prevention 2014
- In-Person Event
- Infectious Disease
- Oct 28 - 31, 2014
- Cape Town, Western Cape, ZA
Quick Links
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com